Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9073584 | 0.84 | TSHR (0.61) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL28371 | 0.77 | TSHR (0.52) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL9317807 | 0.77 | TSHR (0.52) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL874140 | 0.73 | KCNN4 (0.47) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL2261820 | 0.73 | KCNN4 (0.47) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL1315561 | 0.73 | KCNN4 (0.47) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL151981 | 0.73 | TSHR (0.65) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL819164 | 0.73 | TSHR (0.65) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| Chlorotriphenylmethane SCHEMBL461 | 0.73 | TSHR (0.65) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 | |
| SCHEMBL10940043 | 0.73 | TSHR (0.65) | TSHRCYP1A2MAPK1KCNN4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5310917-A | Process for the preparation of 4-substituted-1,4-dihydropydrines | MERCK & CO., INC. (US) | 1994-05-10 | — | — | US | claimed |
| WO-1993006082-A1 | PROCESS FOR THE PREPARATION OF 4-SUBSTITUTED-1,4-DIHYDROPYRIDINES | MERCK & CO., INC. (US) | 1993-04-01 | — | — | WO | claimed |
| EP-0534520-A2 | Process for the preparation of 4-substituted-1,4-dihydropyridines | MERCK & CO. INC. (US) | 1993-03-31 | — | — | EP | claimed |
| CN-108046978-A | A kind of efficient method for preparing iodate benzyl and its derivative | 云南民族大学 | 2018-05-18 | — | — | CN | disclosed |
| EP-1224170-B9 | 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT | BOEHRINGER INGELHEIM PHARMA (DE) | 2017-11-22 | — | — | EP | disclosed |
| EP-2157081-A1 | Indolinones substituted in six locations, their manufacture and their application as medicine | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2010-02-24 | — | — | EP | disclosed |
| EP-1224170-B1 | 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT | BOEHRINGER INGELHEIM PHARMA (DE) | 2009-08-12 | — | — | EP | disclosed |
| US-7514468-B2 | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2009-04-07 | — | — | US | disclosed |
| US-7166599-B2 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-7148249-B2 | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2006-12-12 | — | — | US | disclosed |
| US-20060194813-A1 | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2006-08-31 | — | — | US | disclosed |
| EP-0534520-A2 | Process for the preparation of 4-substituted-1,4-dihydropyridines | MERCK & CO. INC. (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5019587-A | Anticoagulants | BOEHRINGER MANNHEIM GMBH (DE) | 1991-05-28 | — | — | US | disclosed |
| US-4874756-A | CARDIOVASCULAR DISORDERS | BOEHRINGER MANNHEIM GMBH (DE) | 1989-10-17 | — | — | US | disclosed |
| US-4746658-A | 2-phenyl-imidazo-pyrazines, -pyridazines and -triazines | DR. KARL THOMAE GMBH (DE) | 1988-05-24 | — | — | US | disclosed |
| US-4656171-A | 2-phenyl-imidazo-pyrazines, useful as cardiotonics | DR. KARL THOMAE GMBH (DE) | 1987-04-07 | — | — | US | disclosed |
| US-4560402-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA GEIGY CORPORATION (US) | 1985-12-24 | — | — | US | disclosed |
| US-4413124-A | 2-Alkyl-5-alkylsulfonyl-4,6-dihalopyrimidines and the production thereof | CIBA-GEIGY CORPORATION (US) | 1983-11-01 | — | — | US | disclosed |
| US-4412074-A | 2-Alkyl-5-alkyl sulfony 1-4,6-dihalopyrimidines and the production thereof | CIBA-GEIGY CORPORATION (US) | 1983-10-25 | — | — | US | disclosed |
| US-4311514-A | Sulfur-containing alkanecarboxylic acid derivatives with herbicidal and plant growth-regulating action, production thereof and method of use | CIBA-GEIGY CORPORATION (US) | 1982-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194813-A1 | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions | KDR, FLT1, EGFR | TSHR 503/4885CYP1A2 505/4885MAPK1 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.